Jones Financial Companies’s Milestone Pharmaceuticals MIST Stock Holding History

Jones Financial Companies’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.6K	Hold	16,000	–	–	﹤0.01%	3364
2025 Q4	$32.3K	Buy	16,000 +5,000	+45%	+$10.8K	﹤0.01%	2726
2025 Q3	$22K	Hold	11,000	–	–	﹤0.01%	2746
2025 Q2	$20.5K	Hold	11,000	–	–	﹤0.01%	2576
2025 Q1	$9.68K	Hold	11,000	–	–	﹤0.01%	2720
2024 Q4	$26K	Buy	11,000 +10,000	+1,000%	+$17.2K	﹤0.01%	2141
2024 Q3	$1.53K	Sell	1,000 -70	-7%	-$102	﹤0.01%	2732
2024 Q2	$1.41K	Buy	+1,070	New	+$1.72K	﹤0.01%	2229

Other funds holding MIST

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Jones Financial Companies's MIST Position: Q1 2026 in Review

Jones Financial Companies held its Milestone Pharmaceuticals (MIST) position steady in Q1 2026 at 16,000 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3364.

Jones Financial Companies first reported a position in MIST in Q2 2024 and has held it in 8 quarters since. The position peaked at $32.3K in Q4 2025. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

Jones Financial Companies held 16,000 shares of Milestone Pharmaceuticals worth $16.6K as of Q1 2026.
Jones Financial Companies left its Milestone Pharmaceuticals share count unchanged in Q1 2026.
Milestone Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3364 holding.
Jones Financial Companies first reported a position in Milestone Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
Jones Financial Companies's Milestone Pharmaceuticals position peaked at $32.3K in Q4 2025.
86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.